SM
CPXX

Sabby Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Sabby Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-26,500
Closed -$800K – 370
2016
Q2 		$800K Buy
26,500
+1,500
+6% +$30.4K 0.04% 178
2016
Q1 		$276K Sell
25,000
-312,462
-93% -$1.02M 0.01% 244
2015
Q4 		$594K Buy
+337,462
New +$579K 0.03% 225
2015
Q1 		– Sell
-140,234
Closed -$275 – 344
2014
Q4 		$275 Buy
140,234
+33,105
+31% +$68.7K 0.01% 205
2014
Q3 		$271 Sell
107,129
-234,495
-69% -$642K 0.01% 212
2014
Q2 		$1.01M Sell
341,624
-284,453
-45% -$783K 0.04% 152
2014
Q1 		$2.02M Sell
626,077
-53,515
-8% -$181K 0.11% 107
2013
Q4 		$2.18M Buy
+679,592
New +$2.33M 0.14% 81

Sabby Management's CPXX Position: Q3 2016 in Review

Sabby Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 26,500 shares — an estimated $800K sold.

Sabby Management first reported a position in CPXX in Q4 2013 and held it in 8 quarters. The position peaked at $2.18M in Q4 2013. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Sabby Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Sabby Management sold 26,500 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $800K.
  • Sabby Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2013 and held it in 8 quarters.
  • Sabby Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $2.18M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.